160 related articles for article (PubMed ID: 19737071)
1. Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors.
Krawetz R; Taiani JT; Liu S; Meng G; Li X; Kallos MS; Rancourt DE
Tissue Eng Part C Methods; 2010 Aug; 16(4):573-82. PubMed ID: 19737071
[TBL] [Abstract][Full Text] [Related]
2. Overcoming bioprocess bottlenecks in the large-scale expansion of high-quality hiPSC aggregates in vertical-wheel stirred suspension bioreactors.
Borys BS; Dang T; So T; Rohani L; Revay T; Walsh T; Thompson M; Argiropoulos B; Rancourt DE; Jung S; Hashimura Y; Lee B; Kallos MS
Stem Cell Res Ther; 2021 Jan; 12(1):55. PubMed ID: 33436078
[TBL] [Abstract][Full Text] [Related]
3. Stirred suspension bioreactors maintain naïve pluripotency of human pluripotent stem cells.
Rohani L; Borys BS; Razian G; Naghsh P; Liu S; Johnson AA; Machiraju P; Holland H; Lewis IA; Groves RA; Toms D; Gordon PMK; Li JW; So T; Dang T; Kallos MS; Rancourt DE
Commun Biol; 2020 Sep; 3(1):492. PubMed ID: 32895477
[TBL] [Abstract][Full Text] [Related]
4. Matrix-free human pluripotent stem cell manufacturing by seed train approach and intermediate cryopreservation.
Ullmann K; Manstein F; Triebert W; Kriedemann N; Franke A; Teske J; Mertens M; Lupanow V; Göhring G; Haase A; Martin U; Zweigerdt R
Stem Cell Res Ther; 2024 Mar; 15(1):89. PubMed ID: 38528578
[TBL] [Abstract][Full Text] [Related]
5. Generation of human brain region-specific organoids using a miniaturized spinning bioreactor.
Qian X; Jacob F; Song MM; Nguyen HN; Song H; Ming GL
Nat Protoc; 2018 Mar; 13(3):565-580. PubMed ID: 29470464
[TBL] [Abstract][Full Text] [Related]
6. GMP-grade neural progenitor derivation and differentiation from clinical-grade human embryonic stem cells.
Vitillo L; Durance C; Hewitt Z; Moore H; Smith A; Vallier L
Stem Cell Res Ther; 2020 Sep; 11(1):406. PubMed ID: 32948237
[TBL] [Abstract][Full Text] [Related]
7. Scaling up human mesenchymal stem cell manufacturing using bioreactors for clinical uses.
Jankovic MG; Stojkovic M; Bojic S; Jovicic N; Kovacevic MM; Ivosevic Z; Juskovic A; Kovacevic V; Ljujic B
Curr Res Transl Med; 2023; 71(2):103393. PubMed ID: 37163885
[TBL] [Abstract][Full Text] [Related]
8. Understanding cell culture dynamics: a tool for defining protocol parameters for improved processes and efficient manufacturing using human embryonic stem cells.
Kusena JWT; Shariatzadeh M; Thomas RJ; Wilson SL
Bioengineered; 2021 Dec; 12(1):979-996. PubMed ID: 33757391
[TBL] [Abstract][Full Text] [Related]
9. Suicide gene-enabled cell therapy: A novel approach to scalable human pluripotent stem cell quality control.
Gysel E; Larijani L; Kallos MS; Krawetz RJ
Bioessays; 2023 Nov; 45(11):e2300037. PubMed ID: 37582645
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive review of quantum bioreactor cell manufacture: Research and clinical applications.
Hulme CH; Mennan C; McCarthy HS; Davies R; Lan T; Rix L; Perry J; Wright K
Cytotherapy; 2023 Oct; 25(10):1017-1026. PubMed ID: 37162433
[TBL] [Abstract][Full Text] [Related]
11. Platforms for Manufacturing Allogeneic, Autologous and iPSC Cell Therapy Products: An Industry Perspective.
Abraham E; Ahmadian BB; Holderness K; Levinson Y; McAfee E
Adv Biochem Eng Biotechnol; 2018; 165():323-350. PubMed ID: 28534167
[TBL] [Abstract][Full Text] [Related]
12. Automated real-time monitoring of human pluripotent stem cell aggregation in stirred tank reactors.
Schwedhelm I; Zdzieblo D; Appelt-Menzel A; Berger C; Schmitz T; Schuldt B; Franke A; Müller FJ; Pless O; Schwarz T; Wiedemann P; Walles H; Hansmann J
Sci Rep; 2019 Aug; 9(1):12297. PubMed ID: 31444389
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Differentiation of Human Pluripotent Stem Cell-Derived Kidney Precursor Cells inside Mouse Vascularized Bioreactors.
Ranjzad P; Jinks J; Salahi AP; Bantounas I; Derby B; Kimber SJ; Woolf AS; Wong JKF
Nephron; 2020; 144(10):509-524. PubMed ID: 32756058
[TBL] [Abstract][Full Text] [Related]
14. Single-Use Bioreactors for Human Pluripotent and Adult Stem Cells: Towards Regenerative Medicine Applications.
Nogueira DES; Cabral JMS; Rodrigues CAV
Bioengineering (Basel); 2021 May; 8(5):. PubMed ID: 34067549
[TBL] [Abstract][Full Text] [Related]
15. Challenges and Solutions for Commercial Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products.
Lee B; Borys BS; Kallos MS; Rodrigues CAV; Silva TP; Cabral JMS
Bioengineering (Basel); 2020 Mar; 7(2):. PubMed ID: 32231012
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in bioreactors for cell-based therapies.
Stephenson M; Grayson W
F1000Res; 2018; 7():. PubMed ID: 29770207
[TBL] [Abstract][Full Text] [Related]
17. Current status of platelet manufacturing in 3D or bioreactors.
Kweon S; Kim S; Choi HS; Jo K; Park JM; Baek EJ
Biotechnol Prog; 2023; 39(5):e3364. PubMed ID: 37294031
[TBL] [Abstract][Full Text] [Related]
18. Scalable stirred-suspension bioreactor culture of human pluripotent stem cells.
Kehoe DE; Jing D; Lock LT; Tzanakakis ES
Tissue Eng Part A; 2010 Feb; 16(2):405-21. PubMed ID: 19739936
[TBL] [Abstract][Full Text] [Related]
19. Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors.
Shafa M; Sjonnesen K; Yamashita A; Liu S; Michalak M; Kallos MS; Rancourt DE
J Tissue Eng Regen Med; 2012 Jun; 6(6):462-72. PubMed ID: 21761573
[TBL] [Abstract][Full Text] [Related]
20. Suspension culture of undifferentiated human embryonic and induced pluripotent stem cells.
Amit M; Chebath J; Margulets V; Laevsky I; Miropolsky Y; Shariki K; Peri M; Blais I; Slutsky G; Revel M; Itskovitz-Eldor J
Stem Cell Rev Rep; 2010 Jun; 6(2):248-59. PubMed ID: 20431964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
